Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
Pediatric Blood & Cancer|October 6, 2010
National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testingMin H Kang, Malcolm A Smith, Christopher L Morton, et al.
Molecular Cancer Therapeutics|October 14, 2003
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell linesHiroaki Goto, Bo Yang, Denise Petersen, et al.
Cancer Research|June 18, 2003
Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonateYasuyoshi Sohara, Hiroyuki Shimada, Miriam Scadeng, et al.
Cancers|February 13, 2021
Neuroblastoma Invasion Strategies Are Regulated by the Extracellular MatrixCian Gavin, Nele Geerts, Brenton Cavanagh, et al.
Pediatric Blood & Cancer|September 19, 2017
Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing ProgramRaushan T Kurmasheva, Dias Kurmashev, C Patrick Reynolds, et al.
British Journal of Pharmacology|July 22, 2014
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastomaPoonam Sonawane, Hwang Eui Cho, Ashujit Tagde, et al.
Anti-Cancer Drugs|December 16, 2020
The O6-methyguanine-DNA methyltransferase inhibitor O6-benzylguanine enhanced activity of temozolomide + irinotecan against models of high-risk neuroblastomaAshly Hindle, Balakrishna Koneru, Monish Ram Makena, et al.
Frontiers in Oncology|September 3, 2024
Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assayTrevor A Burrow, Balakrishna Koneru, Shawn J Macha, et al.
Molecular Cancer Therapeutics|August 18, 2016
Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma XenograftsNancy E Chen, N Vanessa Maldonado, Vazgen Khankaldyyan, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cellsHyung-Gyoo Kang, Jasmine M Jenabi, Xian Fang Liu, et al.
Pageof 21